<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04181073</url>
  </required_header>
  <id_info>
    <org_study_id>GN17RM666</org_study_id>
    <nct_id>NCT04181073</nct_id>
  </id_info>
  <brief_title>Borg Score Outcomes in Respiratory Compromised Acute Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department</brief_title>
  <acronym>BRAVE</acronym>
  <official_title>The BRAVE Study: Borg Score Outcomes in Respiratory Compromised Acute Exacerbating COPD Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NHS Greater Clyde and Glasgow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aerogen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NHS Greater Clyde and Glasgow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare clinical outcomes in patients with acute COPD treated
      with a vibrating mesh nebuliser (VMN) versus a current standard jet nebuliser (JN), in the
      Emergency Department (ED).

      Participants will be those who meet the inclusion criteria and have a primary diagnosis of
      COPD, and consent to take part in the study. Operators will be clinical staff including
      doctors and nurses who will be trained in the use of the nebulisers.

      Delivery of current treatment standards utilising a VMN compared to a JN will improve symptom
      scores in patients attending ED with COPD exacerbations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, single-centre, open, randomised study to improve management of
      acute COPD exacerbation within the Emergency Department. Adults with severe COPD are
      randomised into 2 groups: vibrating mesh nebuliser or standard jet nebuliser treatment.
      Salbutamol (5mg) and Ipratropium (0.5mg) will be administered via Aerogen Ultra via valved
      mask or a standard jet nebuliser via open face mask/. Two further doses of salbutamol to be
      delivered.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Randomised Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BORG Score</measure>
    <time_frame>30 minutes post treatment</time_frame>
    <description>Change in Reported Dyspnoea. Modified BORG dyspnoea scale. 0 (best) min 10 max (worse)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oscillometry</measure>
    <time_frame>30 minutes post treatment</time_frame>
    <description>Change of Oscillometry data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Escalation of Care</measure>
    <time_frame>During Emergency Department Admission (typically &lt; 4 hours)</time_frame>
    <description>Requirement for NIV (non invasive ventilation) / Intubation / further nebulisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Gas</measure>
    <time_frame>30 minutes post treatment</time_frame>
    <description>Change in blood gases post treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion of Treatment</measure>
    <time_frame>During Emergency Department Admission (typically &lt; 4 hours)</time_frame>
    <description>Time to complete initial nebulisation therapy in ED</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Staff Satisfaction</measure>
    <time_frame>During Emergency Department Admission (typically &lt; 4 hours)</time_frame>
    <description>Reported ED staff satisfaction from main care giver post treatment. Likert 5 point scale. (0 highly dissatisfied 5 highly satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COPD Exacerbation</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Jet Nebuliser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy of one dose of 0.5 MG Ipratropium and 3 doses of 2.5 MG Salbutamol via Jet Nebuliser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibrating Mesh Nebuliser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard therapy of one dose of 0.5 MG Ipratropium and 3 doses of 2.5 MG Salbutamol via Vibrating Mesh Nebuliser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jet Nebuliser</intervention_name>
    <description>Jet Nebuliser</description>
    <arm_group_label>Jet Nebuliser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibrating Mesh Nebuliser</intervention_name>
    <description>Aerogen Device</description>
    <arm_group_label>Vibrating Mesh Nebuliser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Primary presentation with acute exacerbation of COPD

        Exclusion Criteria:

          -  • Unable to give valid consent

               -  Patient unable to speak English

               -  Patients where alternative diagnosis cannot be excluded

               -  Known or suspected pneumonia, pneumothorax, pneumomediastinum, pulmonary oedema,
                  vocal cord dysfunction, aspirated foreign body

               -  Any contraindication to delivering bronchodilators

               -  Need for immediate intubation , ventilation or non-invasive ventilation

               -  Pregnant or lactating

               -  Active palliation considered or expected mortality within 48 hours

               -  Known background/ comorbid respiratory disease associated with chronic or
                  variable airflow obstruction (significant goitre, central lung tumour or other
                  central airway pathology, bronchiectasis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emergency Department Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David J Lowe, MBChB</last_name>
      <phone>0141 232 7600</phone>
      <email>Glasgow.CRF@ggc.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Claire McGroarty, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chris Carlin, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>November 23, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2019</study_first_posted>
  <last_update_submitted>May 16, 2020</last_update_submitted>
  <last_update_submitted_qc>May 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NHS Greater Clyde and Glasgow</investigator_affiliation>
    <investigator_full_name>David Lowe</investigator_full_name>
    <investigator_title>Consultant Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>nebulisation</keyword>
  <keyword>vibrating mesh nebuliser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be stored in Safe Haven GG&amp;C</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>6 months</ipd_time_frame>
    <ipd_access_criteria>Via Safe Haven Committee</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

